Literature DB >> 30317527

Reciprocal regulations between miRNAs and HIF-1α in human cancers.

Wanli Yang1, Jiaojiao Ma1, Wei Zhou1, Bo Cao2, Xin Zhou2, Hongwei Zhang1, Qingchuan Zhao1, Liu Hong3, Daiming Fan1.   

Abstract

Hypoxia inducible factor-1α (HIF-1α) is a central molecule involved in mediating cellular processes. Alterations of HIF-1α and hypoxically regulated microRNAs (miRNAs) are correlated with patients' outcome in various cancers, indicating their crucial roles on cancer development. Recently, an increasing number of studies have revealed the intricate regulations between miRNAs and HIF-1α in modulating a wide variety of processes, including proliferation, metastasis, apoptosis, and drug resistance, etc. miRNAs are a class of small noncoding RNAs which function as negative regulators by directly targeting mRNAs. Evidence shows that miRNAs can be regulated by HIF-1α at transcriptional level. In turn, HIF-1α itself can be modulated by many miRNAs whose alterations have been implicated in tumorigenesis, thus forming a reciprocal regulation network. These findings add a new layer of complexity to our understanding of HIF-1α regulatory networks. Here, we will provide a comprehensive overview of the current advances about the bidirectional interactions between HIF-1α and miRNAs in human cancers. Besides, the review will summarize the roles of miRNAs/HIF-1α crosstalk according to various cellular processes. Finally, the potential values of miRNAs/HIF-1α loops in clinical applications are discussed.

Entities:  

Keywords:  Apoptosis; Cancer; HIF-1α; Metastasis; Proliferation; miRNAs

Mesh:

Substances:

Year:  2018        PMID: 30317527     DOI: 10.1007/s00018-018-2941-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  145 in total

1.  Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing.

Authors:  N S Chandel; D S McClintock; C E Feliciano; T M Wood; J A Melendez; A M Rodriguez; P T Schumacker
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

Review 2.  Hydroxylation of HIF-1: oxygen sensing at the molecular level.

Authors:  Gregg L Semenza
Journal:  Physiology (Bethesda)       Date:  2004-08

3.  New human and mouse microRNA genes found by homology search.

Authors:  Michel J Weber
Journal:  FEBS J       Date:  2005-01       Impact factor: 5.542

4.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

5.  c-Jun NH2-terminal kinase activation contributes to hypoxia-inducible factor 1alpha-dependent P-glycoprotein expression in hypoxia.

Authors:  Katrina M Comerford; Eoin P Cummins; Cormac T Taylor
Journal:  Cancer Res       Date:  2004-12-15       Impact factor: 12.701

6.  Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1 alpha.

Authors:  Denise A Chan; Patrick D Sutphin; Shing-Erh Yen; Amato J Giaccia
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

7.  Hypoxia up-regulates prolyl hydroxylase activity: a feedback mechanism that limits HIF-1 responses during reoxygenation.

Authors:  Gisela D'Angelo; Eric Duplan; Nicole Boyer; Paul Vigne; Christian Frelin
Journal:  J Biol Chem       Date:  2003-07-21       Impact factor: 5.157

Review 8.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

9.  Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene.

Authors:  Katrina M Comerford; Timothy J Wallace; Jörn Karhausen; Nancy A Louis; Michael C Montalto; Sean P Colgan
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

10.  Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.

Authors:  H Zhong; A M De Marzo; E Laughner; M Lim; D A Hilton; D Zagzag; P Buechler; W B Isaacs; G L Semenza; J W Simons
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

View more
  17 in total

Review 1.  Hypoxia-Induced circRNAs in Human Diseases: From Mechanisms to Potential Applications.

Authors:  Qi Huang; Juan Yang; Robby Miguel Wen-Jing Goh; Mingliang You; Lingzhi Wang; Zhaowu Ma
Journal:  Cells       Date:  2022-04-19       Impact factor: 7.666

Review 2.  HIF-1α in Osteoarthritis: From Pathogenesis to Therapeutic Implications.

Authors:  Chu-Yang Zeng; Xi-Feng Wang; Fu-Zhou Hua
Journal:  Front Pharmacol       Date:  2022-07-05       Impact factor: 5.988

Review 3.  CircHIPK3: a promising cancer-related circular RNA.

Authors:  Yalu Zhang; Qiaofei Liu; Quan Liao
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

4.  circRNA_100859 functions as an oncogene in colon cancer by sponging the miR-217-HIF-1α pathway.

Authors:  Peng Zhou; Wei Xie; Hua-Lin Huang; Rong-Qi Huang; Chao Tian; Hong-Bo Zhu; Ying-Huan Dai; Zhi-Yuan Li
Journal:  Aging (Albany NY)       Date:  2020-07-08       Impact factor: 5.682

5.  Bioinformatic analysis reveals MIR502 as a potential tumour suppressor in ovarian cancer.

Authors:  Yan Li; Qi Wang; Ning Ning; Fanglan Tang; Yan Wang
Journal:  J Ovarian Res       Date:  2020-07-13       Impact factor: 4.234

6.  MicroRNA‑628‑5p inhibits cell proliferation and induces apoptosis in colorectal cancer through downregulating CCND1 expression levels.

Authors:  Fei Guo; Jun Xue
Journal:  Mol Med Rep       Date:  2020-01-16       Impact factor: 2.952

7.  Circular RNA HIPK3 Promotes EMT of Cervical Cancer Through Sponging miR-338-3p to Up-Regulate HIF-1α.

Authors:  Weiwei Qian; Tingting Huang; Wen Feng
Journal:  Cancer Manag Res       Date:  2020-01-09       Impact factor: 3.989

Review 8.  MicroRNAs and angiogenesis: a new era for the management of colorectal cancer.

Authors:  Yufei Tang; Shaoqi Zong; Hailun Zeng; Xiaofeng Ruan; Liting Yao; Susu Han; Fenggang Hou
Journal:  Cancer Cell Int       Date:  2021-04-17       Impact factor: 5.722

9.  The effect of CELLFOODTM on radiotherapy or combined chemoradiotherapy: preclinical evidence.

Authors:  Barbara Nuvoli; Bruno Amadio; Giancarlo Cortese; Serena Benedetti; Barbara Antoniani; Antonella Soriani; Mariantonia Carosi; Lidia Strigari; Rossella Galati
Journal:  Ther Adv Med Oncol       Date:  2019-10-13       Impact factor: 8.168

10.  MiR-27a Facilitates Breast Cancer Progression via GSK-3β.

Authors:  Huijin Chen; Yuanyuan Zhang; Xin Cao; Peipei Mou
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.